NAROPIN (General Injectables & Vaccines, Inc)


Welcome to the PulseAid listing for the NAROPIN drug offered from General Injectables & Vaccines, Inc. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: General Injectables & Vaccines, Inc
NON-PROPRIETARY NAME: ropivacaine hydrochloride
SUBSTANCE NAME: ROPIVACAINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: EPIDURAL; INFILTRATION; PERINEURAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-03-11
END MARKETING DATE: 0000-00-00


NAROPIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNAROPIN from General Injectables & Vaccines, Inc
LABELER NAME: General Injectables & Vaccines, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2014-03-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52584-286_a3190270-a817-44a1-b428-03c57fbb3a13
PRODUCT NDC: 52584-286
APPLICATION NUMBER: NDA020533

Other ROPIVACAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Ropivacaine Hydrochloride
AuroMedics Pharma LLCRopivacaine Hydrochloride
Fresenius Kabi USA, LLCNaropin
General Injectables & Vaccines, IncNAROPIN
Hospira, Inc.Ropivacaine Hydrochloride
Sagent PharmaceuticalsRopivacaine Hydrochloride
Sandoz IncRopivacaine Hydrochloride